BMJ

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain

Objective To evaluate whether subjects with knee or hip osteoarthritis (OA) pain on non-steroidal anti-inflammatory drugs (NSAIDs) received greater benefit when tanezumab monotherapy replaced or was ...
BMJ

OP0188 CLINICAL EFFECTIVENESS OF STRATIFIED EXERCISE THERAPY COMPARED TO USUAL EXERCISE THERAPY IN PATIENTS WITH KNEE OSTEOARTHRITIS: A CLUSTER ...

4 Leiden University Medical Center, Department of Orthopaedics, Leiden, Netherlands 5 Leiden University Medical Center, Department of Biomedical Data Sciences, Leiden, Netherlands Objectives The ...
BMJ

THU0446 DIACEREIN PROVEN AS EFFECTIVE AS CELECOXIB IN REDUCING PAIN AND SYMPTOMS IN KNEE OSTEOARTHRITIS PATIENTS IN A MULTICENTRE DOUBLE-BLIND ...

Background: There was a need to ascertain in a clinical trial the comparative efficacy of diacerein, an IL-1 inhibitor, vis-à-vis celecoxib, a COX-2 inhibitor, in relieving knee osteoarthritis (OA) ...
BMJ

EULAR 2024 - Complete PDF

For personal accounts OR managers of institutional accounts * ...
BMJ

Varus and valgus alignment and incident and progressive knee osteoarthritis

Objective Varus and valgus alignment increase medial and lateral tibiofemoral load. Alignment was associated with tibiofemoral osteoarthritis progression in previous studies; an effect on incident ...
BMJ

Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis

3 Centre de Recherche en Epidémiologie et Statistiques (CRESS), Unité Inserm 1153, Université Paris Cité, Paris, France ...
BMJ

CD-19 CAR-T cells for polyrefractory rheumatoid arthritis

‘Poly-refractory’ disease affects 2.7% of patients with rheumatoid arthritis (RA) who have failed different groups of biologic disease-modifying antirheumatic drugs (b-DMARDS) and targeted synthetic ...
BMJ

Table of contents

SpA: Innovative techniques in spondyloarthritis research – Is there light at the end of the tunnel for our patients?
BMJ

THU0306 Clinical specialty setting as a determinant for disease management in patients with psoriatic arthritis: results from loop, a cross-sectional, multi-country ...

Background Evidence suggests that timely and effective management can improve long-term outcomes in patients (pts) with psoriatic arthritis (PsA); however factors influencing treatment management ...
BMJ

2019 update: EULAR RA management recommendations, efficacy and safety systematic literature reviews

‘The main aim of evidence-based treatment recommendations and guidelines are to translate findings from health research into clinical practice. When implemented successfully these should improve ...
BMJ

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

3 Department of Biomolecular Chemistry, Radboud University Nijmegen, Nijmegen, The Netherlands 4 Department of Immunohaematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The ...
BMJ

Anti-midbody antibodies as a possible predictive factor for a special limited or abortive form of systemic sclerosis?

1 Section for Internal Medicine, Department of Rheumatology, University Clinic Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, D-01307 Dresden, Germany 2 Institute for ...